Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular ProfilingEloísa Jantus‐Lewintre, Massimo Barberis, Alessandra Rappa et al.|Molecular Diagnosis & Therapy|2025Cited by 6
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterationsNoelia Martínez-Jáñez, Miguel Quintela-Fandiño, Begoña Bermejo et al.|npj Precision Oncology|2025Cited by 3